To the Editor— Cardiac denervation and its consequences in heart disease
We have read the article by Chung et al1 with great interest. Their experimental findings highlight the risk of ventricular proarrhythmia after cardioneuroablation, a significant concern that dates back to the description of the technique. Although considered safe in healthy individuals,2 the vagal attenuation effect has not been specifically evaluated in patients with heart disease yet, and its impact on this particular population is therefore unknown.